Back

High-density mapping-guided ventricular tachycardia ablation in patients with ischemic cardiomyopathy: outcomes from a tertiary center cohort in Switzerland

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Poster session on atrial fibrillation and supraventricular tachycardia Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Fu Guan

University Hospital Zurich, Zurich (Switzerland)

116 More presentations in this session

Presentation thumbnail
Left atrial strain measurement in patients with heart failure and atrial fibrillation compared to a control group
Doctor L. Herzer (Jena, DE)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation after transcatheter tricuspid valve repair: rhythm control strategies and outcomes
Doctor J. Schipper (Cologne, DE)
Abstract
Presentation thumbnail
Left atrial strain defines functional and structural remodeling in patients with persistent atrial fibrillation
Doctor A. Grosse (Jena, DE)
Abstract Slides Video
Presentation thumbnail
Cryoballoon ablation for atrial fibrillation in young adults: a propensity-score matching comparison with an older cohort
Presentation thumbnail
Procedural safety and outcome of additional left atrial posterior wall ablation using pulse field ablation for atrial fibrillation
Doctor J. Tay Cheong Kiat (Singapore, SG)
Abstract Slides Video

Access the full session

Session thumbnail
Poster session on atrial fibrillation and supraventricular tachycardia

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Ablation of hemodynamically unstable ventricular tachycardia guided by ultra-high density pacemapping and PASO correlation map, a multi-center clinical trial
thumbnail
Congress Presentation
Ventricular tachycardia mapping and ablation using MIXture of well-established approaches. The MIX-VT study
thumbnail
Congress Presentation
Significance of Coherent Mapping in unveiling slow conduction zones of ventricular tachycardia substrate in ischemic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources